ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
0.34
0.00 (0.44%)
At close: May 01, 2025, 3:59 PM
0.37
8.14%
Pre-market: May 02, 2025, 04:51 AM EDT
ReShape Lifesciences Revenue
ReShape Lifesciences reported an annual revenue of $8.01M, reflecting a -7.74% growth. For the quarter ending December 31, 2024, ReShape Lifesciences generated $1.8M in revenue.
Revenue (ttm)
$8.01M
Revenue Growth
-7.74%
Price / Sales Ratio
0.29
Revenue / Employee
$470.94K
Employees
17
Market Cap
3.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 8.01M | -7.74% |
| Dec 31, 2023 | 8.68M | -22.79% |
| Dec 31, 2022 | 11.24M | -17.35% |
| Dec 31, 2021 | 13.6M | +20.36% |
| Dec 31, 2020 | 11.3M | n/a |